References
- Cooper RA. Abnormalities of cell membrane fluidity in the patho-genesis of disease. N Engl J Med 1977; 297: 371–7.
- Kobayashi S, Hirai A, Terano T, Hamazaki T, Tamara Y, Kumagai A. Reduction in blood viscosity by eicosapentaenoic acid. Lancet 1981; 2: 197 (letter).
- Cartwright IJ, Pockley AG, Galloway JH, Greaves M, Preston FE. The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers. Atherosclerosis 1985; 55: 267–81.
- Kamada T, Yamashita T, Baba Y, Kai M, Setoyama S, Chuman Y, Otsuji S. Dietary sardine oil increases erythrocyte membrane fluidity in diabetic patients. Diabetes 1986; 35: 604–11.
- Mortensen JZ, Schmidt EB, Nielsen AH, Dyerberg J. The effect of n-6 and n-3 polyunsaturated fatty acids on hemostasis, blood lipids and blood pressure. Thromb Haemostas 1983; 50: 543–6.
- Singer P, Berger I, Luck K, Taube C, Naumann E, Godicke W. Long-term effect of mackeral diet on blood pressure, serum lipids and thromboxane formation in patients with mild essential hyper-tension. Atherosclerosis 1986; 62: 259–65.
- Kury PG, Ramwell PW, McConnell HM. The effect of prostaglandin El and E2 on the human erythrocyte as monitored by spin labels. Biochim Biophys Res Commun 1974; 56: 476–83.
- Simpson LO, Olds RJ, Hunter JA. Changes in rheological properties of blood of cigarette smokers taking Efamol: a pilot study. Proc Univ Otago Med Sch 1984; 62: 122–3.
- Simpson LO, Shand BI, Olds RJ. The effects of dietary supplement-ation with Efamol on the healing rate of intractable ulcers. NZ Family Physician 1986; 13: 68–70.
- Walsh GP. A GP's use of omega-3 lipids in coronary heart disease. Br J Clin Pract 1984; 38 (Suppl 31): 75–6.